Immunocore Holdings (Immunocore Holdings) 3-Year Revenue Growth Rate : 78.20% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings 3-Year Revenue Growth Rate?

Immunocore Holdings's Revenue per Share for the three months ended in Dec. 2023 was $2.70.

During the past 12 months, Immunocore Holdings's average Revenue per Share Growth Rate was 35.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 78.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 609.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 6 years, the highest 3-Year average Revenue per Share Growth Rate of Immunocore Holdings was 1536.80% per year. The lowest was 78.20% per year. And the median was 903.70% per year.

Competitive Comparison of Immunocore Holdings's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Immunocore Holdings's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunocore Holdings's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunocore Holdings's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Immunocore Holdings's 3-Year Revenue Growth Rate falls into.

Immunocore Holdings 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Immunocore Holdings (NAS:IMCR) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Immunocore Holdings 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Immunocore Holdings's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunocore Holdings (Immunocore Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

6YG:Germany 6YG:Germany

Address

92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY

Website

https://www.immunocore.com

Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.